Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions
Not Applicable
Completed
- Conditions
- Pancreatic Neoplasms
- Registration Number
- NCT02920944
- Lead Sponsor
- Seung Bae Yoon
- Brief Summary
This study aims to examine technical feasibility and diagnostic yield of new 20-gauge Procore needle for EUS-guided fine needle biopsy in solid lesions by comparing with 22-gauge Procore needle. The study design is prospective, randomized study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
- Patients older than 20 years referred to our medical center for EUS-FNB with diagnosed or suspected solid pancreatic masses according to clinical evaluation and imaging studies.
Exclusion Criteria
- cystic pancreatic lesions, patients haemodynamically unstable or with severe coagulopathy (international normalized ratio [INR] > 1.5 or platelet count < 50,000 cells/cubic millimeter [cmm3]), patients unable to suspend anticoagulant/anti-platelet therapy, pregnancy, inability or refusal to give informed consent, and refusal to participate in the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method single diagnostic yield of the histologic core up to 5 minutes after endoscopic ultrasound-guided fine needle biopsy
- Secondary Outcome Measures
Name Time Method total diagnostic yield of the histologic core up to 5 minutes after endoscopic ultrasound-guided fine needle biopsy
Trial Locations
- Locations (1)
The Catholic University of Korea
🇰🇷Seoul, No State, Korea, Republic of
The Catholic University of Korea🇰🇷Seoul, No State, Korea, Republic of